New stomach cancer treatment recommended by NICE after ‘light-touch’ assessment

Durvalumab, in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy, blocks PD-L1 protein and allows the immune system to identify and attack cancer cells.…